<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0001-6002</journal-id>
<journal-title><![CDATA[Acta Médica Costarricense]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. costarric]]></abbrev-journal-title>
<issn>0001-6002</issn>
<publisher>
<publisher-name><![CDATA[Colegio de Médicos y Cirujanos de Costa Rica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0001-60022016000100032</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Características generales y esquemas de tratamiento en pacientes con diabetes tipo 2, participantes en el estudio IDMPS (International Diabetes Management Practice Study en Costa Rica]]></article-title>
<article-title xml:lang="en"><![CDATA[Basic characteristics and treatment regimens in people with type 2 diabetes who participated in the International Diabetes Management Practices Study in Costa Rica]]></article-title>
<article-title xml:lang="en"><![CDATA[Basic characteristics and treatment regimens in people with type 2 diabetes who participated in the International Diabetes Management Practices Study in Costa Rica]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vinocour-Fornieri]]></surname>
<given-names><![CDATA[Mary]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cob-Sánchez]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez-Montero]]></surname>
<given-names><![CDATA[Jose Guillermo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mora-Mora]]></surname>
<given-names><![CDATA[Baudilio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Yung Li]]></surname>
<given-names><![CDATA[Grace]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Clínica Vía San Juan  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af2">
<institution><![CDATA[,Clínica Los Yoses  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital CIMA  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af4">
<institution><![CDATA[,Clínica de Especialidades La Granja  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af5">
<institution><![CDATA[,Clínica Panamericana  ]]></institution>
<addr-line><![CDATA[ San José]]></addr-line>
<country>Costa Rica</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2016</year>
</pub-date>
<volume>58</volume>
<numero>1</numero>
<fpage>32</fpage>
<lpage>35</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_arttext&amp;pid=S0001-60022016000100032&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_abstract&amp;pid=S0001-60022016000100032&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_pdf&amp;pid=S0001-60022016000100032&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Antecedentes: El International Diabetes Management Practice Study es un estudio mundial, observacional, que tiene como propósito determinar el estándar de tratamiento de los pacientes con diabetes mellitus en las diferentes regiones del mundo, y la adherencia a las guías internacionales con respecto al abordaje y manejo de estos pacientes. A nivel mundial, 15016 pacientes con diabetes tipo 2 participaron en el estudio, previamente publicado por Ringborg et al. en la revista International Journal of Clinical Practice, en 2009. La siguiente publicación corresponde a la segunda etapa del estudio que analizó a los pacientes participantes de Costa Rica.  Resultados: En Costa Rica se valoró 49 pacientes de la consulta privada de 5 médicos endocrinólogos, en un periodo que comprendió del 22 de marzo al 24 de abril de 2007. El valor promedio de la glicemia en ayunas para los pacientes fue de 140,45mg/dL ± 56,3. Con respecto al control glicémico, el estudio encontró que el 60% de los participantes presentó una HbA1c &gt; 7%, y el 17,5% de los pacientes presentó HbA1c mayor al 9%. Todos los pacientes valorados estaban recibiendo algún tipo de terapia farmacológica: el 63,6% de los pacientes con hipoglicemiantes orales, y el 45,5% de los pacientes tratados con insulina alcanzó la meta de HbA1c &lt; 7%. Solo el 22,2% de los pacientes tratados con la combinación de hipoglicemiantes orales más insulina, llegó a la meta.  Conclusión: El estudio muestra como la mayoría de los pacientes (60%) no logra alcanzar la meta de un adecuado control glicémico (HbA1c &lt; 7%), aunque se ha establecido que un adecuado control glicémico reduce la incidencia de complicaciones micro y macrovasculares. Debe haber un mayor énfasis en la atención intensiva para mejorar el manejo de los pacientes con diabetes tipo 2 en Costa Rica.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Background: The International Diabetes Management Practice Study was a worldwide observational study with the aim to determine the standard of care of diabetic patients in different regions around the world and the adherence to the international guidelines regarding diabetic care and management. Around the world 15,016 patients with type 2 diabetes were enrolled in this study, published previously by Ringborg et al, in the International Journal of Clinical Practice in 2009. The following study corresponds to the sub study which analyzed the patients who participated in Costa Rica.  Results: In Costa Rica 49 type 2 diabetic patients were recruited from the private practice of 5 endocrinologists from March 22nd to April 24th, 2007. The mean fasting blood sugar value of the patients studied was of 140.45mg/dL ± 56.3. With respect to glycemic control, the study showed that 60% of patients had an HbA1c &gt; 7% and 17.5% of them had a value greater than 9%. All the patients who were evaluated had some type of pharmacologic agent in their therapeutic regimen. Around sixty-three percent (63.6%) of the patients who were treated with oral antidiabetic agents and 45.5% with insulin alone reached the target of an HbA1c &lt; 7%, respectively. To a lesser extent (22.2%) patients who were treated with both types of medications reached that goal.  Conclusion: In this study the majority of patients (60%), did not meet criteria for an adequate glycemic control (HbA1c &lt; 7%) despite the broad scientific evidence available which demonstrates that an adequate glycemic control effectively reduces micro and macrovascular complications. More emphasis needs to be added to improve treatment for patients with type 2 diabetes in Costa Rica.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[diabetes mellitus tipo 2]]></kwd>
<kwd lng="es"><![CDATA[IDMPS (International Diabetes Management Practice Study)]]></kwd>
<kwd lng="es"><![CDATA[HbA1c]]></kwd>
<kwd lng="en"><![CDATA[Type 2 diabetes mellitus]]></kwd>
<kwd lng="en"><![CDATA[IDMPS (International Diabetes Management Practice Study)]]></kwd>
<kwd lng="en"><![CDATA[HbA1c]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ringborg]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cropet]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Gagliardino]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ramachandran]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lindsgren]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resourse use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: Results from the International Diabetes Management Practices Study (IDMPS)]]></article-title>
<source><![CDATA[Int J Clin Pract]]></source>
<year>2009</year>
<volume>63</volume>
<page-range>980-2</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Cull]]></surname>
<given-names><![CDATA[Ca]]></given-names>
</name>
<name>
<surname><![CDATA[Frighi]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Hollman]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1999</year>
<volume>281</volume>
<page-range>2005-12</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sapkota]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Brien]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Greenfield]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Asiani]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes - Components of Interventions]]></article-title>
<source><![CDATA[PLoS ONE]]></source>
<year>2015</year>
<volume>10</volume>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lerman]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherence to Treatment: The Key for Avoiding Long - Term Complications of Diabetes]]></article-title>
<source><![CDATA[Archives of Medical Research]]></source>
<year>2005</year>
<volume>36</volume>
<page-range>300-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Nichols]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Perry]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The burden of treatment in type 2 diabetes]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2004</year>
<volume>27</volume>
<page-range>1535-40</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monnier]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lapinsky]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Colette]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetes patients]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2003</year>
<volume>26</volume>
<page-range>881-5</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>American Diabetes Association. Standards of Medical Care in Diabetes</collab>
<source><![CDATA[Diabetes Care]]></source>
<year>2009</year>
<volume>32</volume>
<page-range>193-203</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<collab>U.K. prospective Diabetes Study group</collab>
<article-title xml:lang=""><![CDATA[UK. prospective diabetes study Overview of 6 years therapy of type II diabetes: A progressive disease]]></article-title>
<source><![CDATA[Diabetes]]></source>
<year>1995</year>
<volume>44</volume>
<page-range>1249-58</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chacra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Escalante]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Litwack]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mestman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[More]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Violante]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An algorithm for the treatment of type 2 diabetes in Latin America]]></article-title>
<source><![CDATA[Diabetes, Obesity and Metabolism]]></source>
<year>2005</year>
<volume>7</volume>
<page-range>148-60</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
